Scott Tarriff - 05 Jan 2023 Form 4 Insider Report for EAGLE PHARMACEUTICALS, INC. (EGRX)

Role
CEO, Director, 10%+ Owner
Signature
/s/ Scott Tarriff
Issuer symbol
EGRX
Transactions as of
05 Jan 2023
Net transactions value
-$111,978
Form type
4
Filing time
09 Jan 2023, 15:33:24 UTC
Previous filing
02 Mar 2022
Next filing
24 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EGRX Common Stock Tax liability $111,978 -3,827 -0.24% $29.26 1,575,879 05 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The disposition reported on this Form 4 represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock units.